Caloglu, MuratCiezki, Jay2024-06-122024-06-1220090090-4295https://doi.org/10.1016/j.urology.2009.01.043https://hdl.handle.net/20.500.14551/24991Prostate brachytherapy is a commonly used modality for the treatment of prostate cancer. After prostate brachytherapy, the prostate-specific antigen (PSA) level may fluctuate and increase temporarily without a clear reason in 30-40% of successfully treated men. This phenomenon is called PSA bounce and engenders anxiety on the part of the patient and physician. Having reviewed the literature we found 19 articles and summarized in the current review to delineate the facts of this relatively common and ambiguous phenomenon. Although several patient and treatment related factors were assessed by studies, only age remained as the most consistent predictor. UROLOGY 74: 1183-1190, 2009. (C) 2009 Elsevier Inc.en10.1016/j.urology.2009.01.043info:eu-repo/semantics/closedAccessExternal-Beam RadiationPsa BounceAndrogen DeprivationSeed ImplantationPatient AgeSimultaneous IrradiationFollow-UpLow-RiskCancerRadiotherapyReview Article74611831190Q2WOS:0002743931000012-s2.0-7084908551419428077Q2